Sibei Tao
- Nephrology top 2%
- Acute Kidney Injury Research 3
- Gout, Hyperuricemia, Uric Acid 3
- Chronic Kidney Disease and Diabetes 2
- Pharmacology top 5%
- Orthodontics top 10%
- Periodontics top 10%
-
- Muscle and Compartmental Disorders 3
-
- Heme Oxygenase-1 and Carbon Monoxide 3
- Epigenetics and DNA Methylation 2
- Renal and related cancers 2
-
- Health disparities and outcomes 2
- Cited by
- NephrologyPharmacologyOrthodontics
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Sibei Tao
22 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Nephrology 344
- Pharmacology 114
- Orthodontics 36
- Periodontics 35
- Biological Psychiatry 16
Countries citing papers authored by Sibei Tao
This map shows the geographic impact of Sibei Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibei Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibei Tao more than expected).
Fields of papers citing papers by Sibei Tao
This network shows the impact of papers produced by Sibei Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibei Tao. The network helps show where Sibei Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sibei Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescencebreakdown → | 2024 | 52 |
| 2 | 2023 | 19 | |
| 3 | 2022 | 17 | |
| 4 | 2022 | 76 | |
| 5 | 2022 | 15 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 98 | |
| 9 | 2020 | 39 | |
| 10 | 2020 | 36 | |
| 11 | 2020 | 20 | |
| 12 | 2019 | 38 | |
| 13 | 2019 | 21 | |
| 14 | 2019 | 10 | |
| 15 | Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI micebreakdown → | 2019 | 305 |
| 16 | 2019 | 7 | |
| 17 | 2018 | 28 | |
| 18 | 2018 | 42 | |
| 19 | 2018 | 89 | |
| 20 | 2017 | 14 |
About Sibei Tao
Sibei Tao is a scholar working on Nephrology, Biological Psychiatry and Health, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include Muscle and Compartmental Disorders (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers), Acute Kidney Injury Research (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Epigenetics and DNA Methylation (2 papers), Renal and related cancers (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Health disparities and outcomes (2 papers). The work is most often cited by research in Nephrology (344 citations), Pharmacology (114 citations) and Orthodontics (36 citations). Sibei Tao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fan Guo, Ping Fu, Rongshuang Huang, Ping Fu, Qian Ren, Liang Ma, Liang Ma, Letian Yang, Xiaoxi Zeng and Jing Liu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.